A new study shows that tumor cells depleted of ARID1A — a protein that acts as a cancer suppressor — become highly sensitive to anticancer poly ADP ribose polymerase (PARP) inhibitor drugs after radiation treatment.
A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England. In making its provisional decision on rucaparib (Rubraca), the National Institute of Health
In the journal Science Immunology, researchers from DTU Health Technology and Jacobs University in Bremen have just published their cutting-edge research demonstrating advancement in detection of a certain type of immune cells, called T cells.
Lung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer (SCC) being one of the common types. Despite improved knowledge of the molecular alterations in SCC,
Researchers at the University of Birmingham have shown that it’s possible to produce a compound with anti-cancer properties directly from feverfew—a common flowering garden plant. The team was able to extract the compound from the
The Air Force has begun to look at whether there’s increased risk for prostate cancer among its fighter pilots. A new investigation by McClatchy shows just how serious the problem may be. The fighter pilot
Investigators at St. Jude Children’s Research Hospital and Massachusetts General Hospital, alongside others, have revealed the cells of origin for specific subtypes of medulloblastoma, the most common malignant pediatric brain tumor. The work also has
Breast implant maker Allergan Inc. issued a worldwide recall Wednesday for certain textured models after regulators alerted the company to a heightened cancer risk with the devices. The U.S. Food and Drug Administration said it
A woman has been left “unnecessarily traumatized” after she was misdiagnosed with an aggressive form of breast cancer that forced her to undergo a grueling amount of treatments and surgery. Sarah Boyle is still struggling
Drinking coffee does not change a person’s risk of being diagnosed with or dying from cancer, a new QIMR Berghofer study has found. The research findings have been published in the International Journal of Epidemiology.